cholecystokinin CCK
Selected indexed studies
- Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease. (Front Neuroendocrinol, 2024) [PMID:38346453]
- Cholecystokinin (CCK) Regulation of Pancreatic Acinar Cells: Physiological Actions and Signal Transduction Mechanisms. (Compr Physiol, 2019) [PMID:30873601]
- Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes. (Peptides, 2018) [PMID:29412823]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease. (2024) pubmed
- Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes. (2018) pubmed
- Cholecystokinin-dopamine interactions. (1991) pubmed
- Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding. (1990) pubmed
- Cholecystokinin (CCK) and its receptors (CCK1R and CCK2R) in chickens: functional analysis and tissue expression. (2023) pubmed
- Molecular cloning of cholecystokinin (CCK) and CCK-A receptor and mechanism of CCK-induced gastrointestinal motility in Suncus murinus. (2022) pubmed
- Cholecystokinin (CCK) Regulation of Pancreatic Acinar Cells: Physiological Actions and Signal Transduction Mechanisms. (2019) pubmed
- Progress in developing cholecystokinin (CCK)/gastrin receptor ligands that have therapeutic potential. (2007) pubmed
- Cholecystokinin (CCK) assays. (2001) pubmed
- [Cholecystokinin (CCK). Physiology and clinical use]. (1970) pubmed